Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mesenchymal stem cells. Basic science and future clinical use].

Katarina Le Blanc1

  • 1Hematologiska kliniken, Huddinge Universitetssjukhus. Katarina.Leblanc@medhs.ki.se

Lakartidningen
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open phase I/IIa study evaluating safety, patient-reported outcomes and voice function after surgery, local administration of mesenchymal stromal cells and voice training in patients with vocal fold scarring and dysphonia.

Stem cell research & therapy·2026
Same author

Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directions.

Cytotherapy·2025
Same author

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

Cytotherapy·2025
Same author

Correction: Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT.

Bone marrow transplantation·2025
Same author

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells.

Cytotherapy·2025
Same author

Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles.

Stem cell research & therapy·2024
Same journal

[Access to health data for research].

Lakartidningen·2026
Same journal

[CANVAS and RFC1-related disease - a broad clinical spectrum from cough and neuropathy to cerebellar ataxia].

Lakartidningen·2026
Same journal

[Choosing wisely in Swedish neuroradiology].

Lakartidningen·2026
Same journal

[Asthma among athletes - prevalence, diagnosis and treatment].

Lakartidningen·2026
Same journal

[Minimally invasive surgery for colorectal cancer was introduced in a safe and well controlled manner].

Lakartidningen·2026
Same journal

[Modified Valsalva maneuver induced an asymptomatic polymorphic ventricular tachycardia].

Lakartidningen·2026
See all related articles

Mesenchymal stem cells from adult bone marrow can be expanded and differentiated. These cells enhance hematopoietic stem cell engraftment and reduce graft-versus-host disease.

Area of Science:

  • * Regenerative Medicine
  • * Stem Cell Biology
  • * Immunology

Context:

  • * Mesenchymal stem cells (MSCs) are sourced from adult human iliac crest bone marrow aspirates.
  • * MSCs possess multipotent differentiation capabilities into various cell types, including cardiac, bone, adipocytes, and muscle cells, both in vitro and in vivo.
  • * These cells secrete growth factors crucial for hematopoiesis and immune modulation.

Purpose:

  • * To investigate the therapeutic potential of mesenchymal stem cells.
  • * To evaluate the safety and efficacy of MSC transplantation.
  • * To explore the role of MSCs in enhancing hematopoietic stem cell transplantation outcomes.

Summary:

  • * Ex vivo expanded mesenchymal stem cells retain their differentiation potential.

Related Experiment Videos

  • * Undifferentiated MSCs produce growth factors influencing hematopoiesis and lymphocyte function.
  • * MSCs are well-tolerated in human and animal transplants, with differentiation guided by local tissue factors.
  • * Co-transplantation with hematopoietic cells improves engraftment and mitigates graft-versus-host disease.

    • Impact:

    • * Mesenchymal stem cells show promise as a cell therapy for regenerative medicine.
    • * MSCs can improve the success rates and reduce complications associated with hematopoietic stem cell transplantation.
    • * The findings support further clinical investigation of MSCs in transplantation settings.